key areas to be covered l overview of advertising arrangements l the review - new advertising...
TRANSCRIPT
Key Areas to be Covered Key Areas to be Covered
Overview of advertising arrangements The Review - New Advertising
Arrangements The Approval Process Complaints about advertisements of
therapeutic goods
Overview of advertising arrangements The Review - New Advertising
Arrangements The Approval Process Complaints about advertisements of
therapeutic goods
Advertising - What and to Whom?
Advertising - What and to Whom?
Consumers Unscheduled, S2, some S3 and devices
Healthcare professionals Entire spectrum
Consumers Unscheduled, S2, some S3 and devices
Healthcare professionals Entire spectrum
The LegislationThe Legislation
Trade Practices Act Broadcasting Services Act Therapeutic Goods Act and Regulations
Trade Practices Act Broadcasting Services Act Therapeutic Goods Act and Regulations
The Trade Practices Act 1974The Trade Practices Act 1974
Commercial conduct in general prevents misleading marketing practices prevents restrictive trade practices
Consumer safety and protection standards for product safety and
information
Commercial conduct in general prevents misleading marketing practices prevents restrictive trade practices
Consumer safety and protection standards for product safety and
information
The Broadcasting Services Act 1992
The Broadcasting Services Act 1992
Advertisements relating to medicines Delegation of approval function
PMAA since 1991
Advertisements relating to medicines Delegation of approval function
PMAA since 1991
The Therapeutic Goods Act 1989
The Therapeutic Goods Act 1989
Major legislative control Uniformity across States and Territories ARTG Parts of TGAC incorporated
Major legislative control Uniformity across States and Territories ARTG Parts of TGAC incorporated
How to identify therapeutic goods
How to identify therapeutic goods
Therapeutic claims Product Categories
Listable AUST L Registrable AUST R Exempt
Therapeutic claims Product Categories
Listable AUST L Registrable AUST R Exempt
Definition of AdvertisementDefinition of Advertisement
Any statement, pictorial representation or design
Intended to, whether directly or indirectly to
Promote the use or supply of goods Product labels - a form of advertising
Any statement, pictorial representation or design
Intended to, whether directly or indirectly to
Promote the use or supply of goods Product labels - a form of advertising
Amendment 40018 December 1997Amendment 400
18 December 1997 Defining the TGACC
Complaints Resolution Panel
Defining the TGACC
Complaints Resolution Panel
Amendment 400 - AdvertisingAmendment 400 - Advertising
Definining mainstream media Formal approval - approval number Responsibility of sponsor/advertiser Responsibility of publishers (42D)
Definining mainstream media Formal approval - approval number Responsibility of sponsor/advertiser Responsibility of publishers (42D)
The Therapeutic Goods Advertising Code Council
today
The Therapeutic Goods Advertising Code Council
today Manufacturing and supply Industry Advertisers Healthcare professionals Consumers Government Observers
Manufacturing and supply Industry Advertisers Healthcare professionals Consumers Government Observers
Formal Approval of Advertisements
Formal Approval of Advertisements
Delegation of approval function to industry CHC: print ads for complementary
healthcare products PMAA: non-prescription medicines
Appeals mechanism for non-approved ads
Delegation of approval function to industry CHC: print ads for complementary
healthcare products PMAA: non-prescription medicines
Appeals mechanism for non-approved ads
The Complaints Resolution Panel
The Complaints Resolution Panel
Members Consumers Healthcare professionals Government Industry
Complaints about print advertisements No similar mechanism for broadcast ads
Members Consumers Healthcare professionals Government Industry
Complaints about print advertisements No similar mechanism for broadcast ads
Self-regulatory ArrangementsSelf-regulatory Arrangements
Non-mainstream advertising Industry bridges the gap
CRC of CHC Complaints Panel of PMAA
Non-mainstream advertising Industry bridges the gap
CRC of CHC Complaints Panel of PMAA
SummarySummary
3 Main pieces of legislation Therapeutic Goods Act and Regs TGACC and CRP Formal approval legislated Approval delegated to Industry
3 Main pieces of legislation Therapeutic Goods Act and Regs TGACC and CRP Formal approval legislated Approval delegated to Industry
Key Areas Key Areas
Overview of advertising arrangements The Review - New Advertising
Arrangements The Approval Process Complaints about advertisements of
therapeutic goods
Overview of advertising arrangements The Review - New Advertising
Arrangements The Approval Process Complaints about advertisements of
therapeutic goods
NEW ADVERTISING ARRANGEMENTS
NEW ADVERTISING ARRANGEMENTS
Areas to Be CoveredAreas to Be Covered Overview of reform process The new Therapeutic Goods Advertising
Code “The Guidelines” Overview of regulatory reforms
Overview of reform process The new Therapeutic Goods Advertising
Code “The Guidelines” Overview of regulatory reforms
The ReviewReforms Since 1998
The ReviewReforms Since 1998
The Govt/Industry Working Party Regulation of complementary
healthcare products Deficiencies of the old TGAC
Restricted-product indications/information Emphasis on illness and disease Not reflecting current values
The Govt/Industry Working Party Regulation of complementary
healthcare products Deficiencies of the old TGAC
Restricted-product indications/information Emphasis on illness and disease Not reflecting current values
Agreement for New CodeAgreement for New Code Greater orientation towards health and well-being
Greater range of permissible representations in advertising
Ensuring a level playing field
Deregulation without compromising public health and safety
Greater orientation towards health and well-being
Greater range of permissible representations in advertising
Ensuring a level playing field
Deregulation without compromising public health and safety
The Broader Context of the Review
The Broader Context of the Review
Office of Complementary Medicines Elevating the status of CMEC Major reform of ELF
Office of Complementary Medicines Elevating the status of CMEC Major reform of ELF
Objectives of the ReviewObjectives of the Review
Start new Code with clean sheet Principle based Code New Code to reflect current values User-friendly, practical, all in one
document Evergreen - requiring minimum
legislative amendments
Start new Code with clean sheet Principle based Code New Code to reflect current values User-friendly, practical, all in one
document Evergreen - requiring minimum
legislative amendments
Objectives (continued)Objectives (continued)
Clarify issues relating to claim substantiation
Starting point- all existing permissible representations
Strengthening the TGA’s ability to act: timeliness and teeth
Deregulatory approach without compromising public health and safety
Clarify issues relating to claim substantiation
Starting point- all existing permissible representations
Strengthening the TGA’s ability to act: timeliness and teeth
Deregulatory approach without compromising public health and safety
The Review ProcessThe Review Process
TGACC to oversee the Review Task Force:
CHC, CMEC, CHF, PMAA, TGA, APMA ASM’s
TGACC to oversee the Review Task Force:
CHC, CMEC, CHF, PMAA, TGA, APMA ASM’s
Guidelines for Levels of Evidence
Guidelines for Levels of Evidence
Sponsors required to hold evidence - April 99 amendment
Need for guidance indentified CMEC and Working Party developed
guidelines
Sponsors required to hold evidence - April 99 amendment
Need for guidance indentified CMEC and Working Party developed
guidelines
SummarySummary Contemporary and flexible Code Legislative underpinning for the Code Extended range of claims Guidelines for substantiating evidence Safeguards for consumers Regulatory amendments to underpin
changes
Contemporary and flexible Code Legislative underpinning for the Code Extended range of claims Guidelines for substantiating evidence Safeguards for consumers Regulatory amendments to underpin
changes
Tracking ProgressTracking Progress Overview of reform process The new Therapeutic Goods
Advertising Code “The Guidelines” Overview of regulatory reforms
Overview of reform process The new Therapeutic Goods
Advertising Code “The Guidelines” Overview of regulatory reforms
Rationale - OutcomesRationale - Outcomes
Clean sheet Principle based Open to interpretation - flexible Evergreen Consistency across all media Reflect current social values
Clean sheet Principle based Open to interpretation - flexible Evergreen Consistency across all media Reflect current social values
Clause 1- Object of the CodeClause 1- Object of the Code
The key elements: Socially responsible marketing and
promotion Desired outcome-Quality use of medicines WHO Ethical Criteria (Appendix 1) Context and total presentation of ads -
interpretation and application
The key elements: Socially responsible marketing and
promotion Desired outcome-Quality use of medicines WHO Ethical Criteria (Appendix 1) Context and total presentation of ads -
interpretation and application
Clause 2 - DefinitionsClause 2 - Definitions
Advertisement Label Mainstream media Healthcare professional (Appendix 2) Sponsor Therapeutic goods and therapeutic use
Advertisement Label Mainstream media Healthcare professional (Appendix 2) Sponsor Therapeutic goods and therapeutic use
Clause 3 - Compliance and Application
Clause 3 - Compliance and Application
Compliance with TPA, Therapeutic Goods Act and other legislation
Consumer ads - entire Code applies Healthcare professional ads (Appendix
2) - industry codes
Compliance with TPA, Therapeutic Goods Act and other legislation
Consumer ads - entire Code applies Healthcare professional ads (Appendix
2) - industry codes
Clause 3 (contd)Clause 3 (contd)
Information - generic or branded Advertisement - generic or branded Bona fide news, public interest - Code
does not apply Mainstream ads - formal approval
(Appendix 3)
Information - generic or branded Advertisement - generic or branded Bona fide news, public interest - Code
does not apply Mainstream ads - formal approval
(Appendix 3)
Clause 4 - PrinciplesClause 4 - Principles
Clause 4.1- General 4.1.1Ads for therapeutic goods must:
(a) Comply with the statute and common law
(b) Contain correct and balanced statements and claims already verified.
Clause 4.1- General 4.1.1Ads for therapeutic goods must:
(a) Comply with the statute and common law
(b) Contain correct and balanced statements and claims already verified.
Clause 4.1 (continued)Clause 4.1 (continued) Clause 4.1.2 Ads must not:
(a) arouse unwarranted expectations
(b) lead to inappropriate self-diagnosing and treatment
(c) mislead directly or indirectly
(d) abuse trust, exploit, bring about fear or distress
(e) lead to belief that consumer is suffering from serious ailment or harm coming to consumer
Clause 4.1.2 Ads must not:
(a) arouse unwarranted expectations
(b) lead to inappropriate self-diagnosing and treatment
(c) mislead directly or indirectly
(d) abuse trust, exploit, bring about fear or distress
(e) lead to belief that consumer is suffering from serious ailment or harm coming to consumer
Clause 4.1.2 (continued)Clause 4.1.2 (continued)
(f) inappropriate or excessive consumption
(g) infallible, unfailing, magical, a certain, guaranteed or sure cure
(h) effective in all cases of a condition
(i) safe, no harm, no side-effects
(j) directed to minors, except for those goods in Appendix 5
(f) inappropriate or excessive consumption
(g) infallible, unfailing, magical, a certain, guaranteed or sure cure
(h) effective in all cases of a condition
(i) safe, no harm, no side-effects
(j) directed to minors, except for those goods in Appendix 5
Appendix 5Appendix 5 Therapeutic goods not subject to Clause 4.1.2
(j) tampons topical preparations for acne sunscreens SPF 15+ condoms and personal lubricants bandages and dressings devices for management for chronic conditions
under medical supervision
Therapeutic goods not subject to Clause 4.1.2 (j) tampons topical preparations for acne sunscreens SPF 15+ condoms and personal lubricants bandages and dressings devices for management for chronic conditions
under medical supervision
Clause 4.2 - Scientific Information
Clause 4.2 - Scientific Information
Accurate, balanced, not misleading Appropriate terminology, readily
understood Research results to identify researcher
or sponsor
Accurate, balanced, not misleading Appropriate terminology, readily
understood Research results to identify researcher
or sponsor
Clause 4.3Comparative Advertising
Clause 4.3Comparative Advertising
Balanced, not misleading Factual, reflect body of scientific
evidence Competitor product harmful or
ineffectual
Balanced, not misleading Factual, reflect body of scientific
evidence Competitor product harmful or
ineffectual
Clause 4.4 - Professional Recommendation
Clause 4.4 - Professional Recommendation
Clause 4.4.1- endorsement not permissible by: government agency or healthcare
professional except for availability - place and price
Clause 4.4.1- endorsement not permissible by: government agency or healthcare
professional except for availability - place and price
Clause 4.4.2 - Endorsement Permitted
Clause 4.4.2 - Endorsement Permitted
Bodies or associations, under certain conditions: body or association named authenticated nature disclosed valuable consideration disclosed
Bodies or associations, under certain conditions: body or association named authenticated nature disclosed valuable consideration disclosed
Clause 4.5 - TestimonialsClause 4.5 - Testimonials
Must not breach Code Documented, genuine, not misleading Exceptional cases not depicted as
typical
Must not breach Code Documented, genuine, not misleading Exceptional cases not depicted as
typical
Clause 4.6 - SamplesClause 4.6 - Samples
Advertisements may not contain offer of sample
Advertisements may not contain offer of sample
Clause 5 - ProhibitionsClause 5 - Prohibitions
Clause 5.1 No references allowed: Appendix 6 Part 1:
Abortifacient action Neoplastic disease STD’s HIV/AIDS Mental illness
Clause 5.1 No references allowed: Appendix 6 Part 1:
Abortifacient action Neoplastic disease STD’s HIV/AIDS Mental illness
Clause 5 & Appendix 6 Clause 5 & Appendix 6
Clause 5.2 Restricted representations References allowed on prior approval
from TGA Appendix 6 Part 2:
Table 1: Serious manifestations of diseases
Clause 5.2 Restricted representations References allowed on prior approval
from TGA Appendix 6 Part 2:
Table 1: Serious manifestations of diseases
“Serious” Defined“Serious” Defined
Inappropriate to be diagnosed and/or treated without consulting a healthcare professional
Beyond the ability of the average consumer to evaluate and treat accurately without supervision by a healthcare professional
Inappropriate to be diagnosed and/or treated without consulting a healthcare professional
Beyond the ability of the average consumer to evaluate and treat accurately without supervision by a healthcare professional
Permissible Representations - The Glossary
Permissible Representations - The Glossary
Examples of currently permissible representations
New representations added in future
Examples of currently permissible representations
New representations added in future
Clause 6 - Minimum Requirements
Clause 6 - Minimum Requirements
Clause 6.1 Ads of unbranded therapeutic goods
Only 6.2 (b) applies (plus rest of Code)
Clause 6.1 Ads of unbranded therapeutic goods
Only 6.2 (b) applies (plus rest of Code)
Clause 6 - branded adsClause 6 - branded ads Trade name Approved indications Ingredients OR ‘mandatory’(not direct
marketing & Internet) “Use only as directed” For symptom relief: ‘mandatory’ Advertisable S3’s - ‘mandatory’
Trade name Approved indications Ingredients OR ‘mandatory’(not direct
marketing & Internet) “Use only as directed” For symptom relief: ‘mandatory’ Advertisable S3’s - ‘mandatory’
Clause 7 - Specific CategoriesClause 7 - Specific Categories Clause 7.1 - Analgesics
Applies to ‘primary’ internal analgesics One of 2 mandatory statements in all
media Not permissible:
• safe
• relax, relieve tension, sedate or stimulate
Clause 7.1 - Analgesics Applies to ‘primary’ internal analgesics One of 2 mandatory statements in all
media Not permissible:
• safe
• relax, relieve tension, sedate or stimulate
Clause 7.2 - VitaminsClause 7.2 - Vitamins
Not permissible: vitamins a substitute for good nutrition or
balance diet, or superior to or more beneficial than dietary
nutrients
Not permissible: vitamins a substitute for good nutrition or
balance diet, or superior to or more beneficial than dietary
nutrients
Appendix 4 - Appeals and Complaints
Appendix 4 - Appeals and Complaints
Non-approval - mechanism for appeal Complaints about advertisements
Non-approval - mechanism for appeal Complaints about advertisements
Tracking ProgressTracking Progress Overview of reform process The new Therapeutic Goods Advertising
Code “The Guidelines” Overview of regulatory reforms
Overview of reform process The new Therapeutic Goods Advertising
Code “The Guidelines” Overview of regulatory reforms
Tracking ProgressTracking Progress Overview of reform process The new TGAC “The Guidelines” Overview of regulatory reforms
Overview of reform process The new TGAC “The Guidelines” Overview of regulatory reforms
Guidelines for the Levels and Kinds of Evidence to
Support Claims for Therapeutic Goods
Guidelines for the Levels and Kinds of Evidence to
Support Claims for Therapeutic Goods
Principles:Principles:
Sponsors must hold adequate evidence to support all claims
Claims must be true, valid and not misleading, and consistent with recorded use on ARTG
Claims should not lead to unsafe or inappropriate use of a product
Sponsors must hold adequate evidence to support all claims
Claims must be true, valid and not misleading, and consistent with recorded use on ARTG
Claims should not lead to unsafe or inappropriate use of a product
Claim TypesClaim Types
Registrable claims Require high level evidence. Must be
evaluated by expert committee
Listable claims Require evidence appropriate to the nature
of the claim. Sponsor must have access to the evidence.
Registrable claims Require high level evidence. Must be
evaluated by expert committee
Listable claims Require evidence appropriate to the nature
of the claim. Sponsor must have access to the evidence.
Kinds of evidence which may support claims
Kinds of evidence which may support claims
Scientific evidence
Evidence based on traditional use
Scientific evidence
Evidence based on traditional use
Claims based on Scientific Evidence
Claims based on Scientific Evidence
Scientific evidenceScientific evidence
Categorised as:
Primary- High
- Medium
- General
Non-primary ( supporting evidence)
Categorised as:
Primary- High
- Medium
- General
Non-primary ( supporting evidence)
Claims based on Scientific EvidenceClaims based on Scientific Evidence
High
Medium
General
High
Medium
General
High level claims - scientificHigh level claims - scientific
Treats/cures/manages
Prevents
Vitamin and mineral deficiency diseases
All claims referring to serious diseases/disorders
Treats/cures/manages
Prevents
Vitamin and mineral deficiency diseases
All claims referring to serious diseases/disorders
Medium level claims - scientificMedium level claims - scientific
Health enhancement
Risk Reduction
Symptomatic relief of named (non-serious) diseases/disorders
Health enhancement
Risk Reduction
Symptomatic relief of named (non-serious) diseases/disorders
General level claims - scientificGeneral level claims - scientific
Health maintenance
Nutritional support
Vitamin or mineral supplementation
Relief of symptoms
Health maintenance
Nutritional support
Vitamin or mineral supplementation
Relief of symptoms
Claims based on Evidence of Traditional Use
Claims based on Evidence of Traditional Use
Evidence of Traditional UseEvidence of Traditional Use
Medium level - need medium level evidence
General level - need general level evidence
Medium level - need medium level evidence
General level - need general level evidence
General level scientific evidence
General level scientific evidence
Descriptive studies or reports of relevant expert committees
Texts such as approved Pharmacopoeias/ monographs or other evidence based texts
Descriptive studies or reports of relevant expert committees
Texts such as approved Pharmacopoeias/ monographs or other evidence based texts
Medium level scientific evidenceMedium level scientific evidence Evidence obtained from well designed controlled trials
without randomisation. In the case of a homeopathic preparation, evidence from well designed, controlled homeopathic proving OR
Evidence obtained from well designed analytical studies, preferably from more than one centre or research group, including epidemiological cohort or case-control studies OR
Evidence from multiple time series with or without intervention, including population and ecological studies.
Evidence obtained from well designed controlled trials without randomisation. In the case of a homeopathic preparation, evidence from well designed, controlled homeopathic proving OR
Evidence obtained from well designed analytical studies, preferably from more than one centre or research group, including epidemiological cohort or case-control studies OR
Evidence from multiple time series with or without intervention, including population and ecological studies.
Sources of most medium level evidence will be peer reviewed published papers and evidence based reference texts. Web sites evaluating peer reviewed research may be a source of suitable evidence.
High level scientific evidenceHigh level scientific evidence Evidence obtained from a systematic review of all
relevant control trials eg Cochrane review OR Evidence obtained from at least one properly
designed (preferably multi-centre) randomised double blind trial. It is preferable to have data from at least two independent trials, but in some cases one large well conducted trial may suffice.
Evidence obtained from a systematic review of all relevant control trials eg Cochrane review OR
Evidence obtained from at least one properly designed (preferably multi-centre) randomised double blind trial. It is preferable to have data from at least two independent trials, but in some cases one large well conducted trial may suffice.
There is a Complementary medicine field of study within Cochrane
General level traditional evidence
General level traditional evidence
One of TGA approved Pharmacopoeia/Monograph 3 independent written histories of use in
the classical or traditional medical literature Availability through any country’s
government public dispensaries for the indication claimed
One of TGA approved Pharmacopoeia/Monograph 3 independent written histories of use in
the classical or traditional medical literature Availability through any country’s
government public dispensaries for the indication claimed
Medium level traditional evidenceMedium level traditional evidence
Two of TGA approved Pharmacopoeia TGA approved Monograph 3 independent written histories of use in
the classical or traditional medical literature Availability through any country’s
government public dispensaries for the indication claimed
Two of TGA approved Pharmacopoeia TGA approved Monograph 3 independent written histories of use in
the classical or traditional medical literature Availability through any country’s
government public dispensaries for the indication claimed
Tracking ProgressTracking Progress
Overview of reform process The new TGAC “The Guidelines” Overview of regulatory reforms
Overview of reform process The new TGAC “The Guidelines” Overview of regulatory reforms
Overview of Regulatory ReformsOverview of Regulatory Reforms
Current situation:• Non-mainstream advertisements -
comply with specified parts of the Code• Mainstream print and Broadcast
advertisements - comply with the entire CodeNew situation:• All advertisements will be required to
comply with the entire Code
Current situation:• Therapeutic devices - not subject to
Complaints Resolution Panel (CRP)
New situation:• Therapeutic devices - subject to
Complaints Resolution Panel (CRP)
Current situation:• Difficulties separating ‘generic’ information
from advertising
New situation:• ‘Generic’ information defined as a
separate category and subject to parts of the Code
Current situation:• Clause 4 indicates many prohibited
conditions
New situation:• Clause 5 prohibits 5 conditions• Short list of other restricted
representations
New situation:• CMEC or MEC can recommend a
Regulation 9 exemption for a restricted condition (ie: for labelling purposes)
•TGACC can recommend a Regulation 7A(2) exemption for a restricted condition (ie: for advertising purposes)
New situation:• Role of the Complaints Resolution Panel
(CRP) enhanced : consider a broader range of
advertisements handle anonymous complaints consider issues not raised in a
complaint or in a withdrawn complaint call for substantiating evidence and
seeking expert advice on it
New situation (cont.): withdraw an advertisement’s approval
and require: the discontinuance of an
advertisement the publication of a retraction or
correction the recovery and destruction of
offending advertisements two alternate memberssecretariat to make initial enquiries report to the TGACC
Current situation:• Schedule 4 (Regulations) references
clause 4 of the old Advertising Code
New situation:• All references to clause 4 will be
replaced by clause 5 of the new Code (ie: includes prohibited and restricted representations)
Remaining AreasRemaining Areas
Overview of advertising arrangements The Review - New Advertising
Arrangements Complaints about advertisements of
therapeutic goods The Approval Process
Overview of advertising arrangements The Review - New Advertising
Arrangements Complaints about advertisements of
therapeutic goods The Approval Process
COMPLAINTS ABOUT ADVERTISEMENTS
COMPLAINTS ABOUT ADVERTISEMENTS
The Complaints Resolution Panel
The Complaints Resolution Panel
•Mainstream print and specified media
•Broadcast•Non-mainstream print
Advertisements:
Response ???
Non-mainstream print advertisement
Non-prescription and complementary medicines
PMAA Complaints Panel CHC Complaints Resolution Committee (CRC)
Chemicals and Non-prescription Medicines Branch
CNPM Co-ordination Unit
Recalls UnitAdvertising Unit Drug Listing Unit
Surveillance Unit
Response ???
Non-prescription/ complementary medicine
Broadcast advertisement
Non-prescription/ complementary medicine
- Approval -
Complaints Resolution Panel (CRP)
PMAA PMAA and CHC
Response ???
Mainstream print and specified media advertisement
Secretary/Secretary’s delegate
Chemicals and Non-prescription Medicines Branch
CNPM Co-ordination Unit
Recalls UnitAdvertising Unit Drug Listing Unit
Surveillance Unit
Response ???
THE FORMAL APPROVAL OF ADVERTISEMENTS
THE FORMAL APPROVAL OF ADVERTISEMENTS
CHC- print - complementary PMAA print - OTC & all broadcast Submit
Script for ad Listing certificate Coded/approved indications Label
CHC- print - complementary PMAA print - OTC & all broadcast Submit
Script for ad Listing certificate Coded/approved indications Label
WebsiteWebsite
May 2000 Code & Glossary Levels of Evidence FAQ’s & How to’s Links
May 2000 Code & Glossary Levels of Evidence FAQ’s & How to’s Links